(Q33942871)

30 July 2017

1 reference

title

Update on the interaction between aspirin and angiotensin-converting enzyme inhibitors (English)

1 reference

30 July 2017

1 reference

Nawarskas JJ

1

1 reference

30 July 2017

Spinler SA

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

698-710

1 reference

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Interaction between enalapril and aspirin on mortality after acute myocardial infarction: subgroup analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Antiplatelet agents and survival: a cohort analysis from the Studies of Left Ventricular Dysfunction (SOLVD) trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Combining salicylate and enalapril in patients with coronary artery disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Is aspirin safe for patients with heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

PlA2 polymorphism and efficacy of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

Consensus recommendations for the management of chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.7.698.35168

10.1592/PHCO.20.7.698.35168

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference